Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text (PDF, 440K) PPT slides of all figures Alert me when this article is cited Services Email this article Similar articles in this journal Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Dove, A. W. Search for Related Content PubMed Articles by Dove, A. W. Social Bookmarking                            What's this?

© The Rockefeller University Press, 0021-9525/2002/7/193 $5.00
The Journal of Cell Biology, Volume 158, Number 2, July 22, 2002 193-193

Signaling from strange places

The location of Scotin (green) suggests a function for the ER in apoptosis.

The tumor suppressor p53 can act as a transcription factor, but only a few p53-activated genes have been found, and the biochemical basis of p53-mediated apoptosis has been especially difficult to probe. Now, Bourdon et al. describe the discovery and characterization of a novel p53-inducible proapoptotic gene (page 235).

By comparing gene expression in normal and p53-knockout mice exposed to ionizing radiation, the authors identified Scotin, a novel gene that is directly trans-activated when p53 binds to a specific site in its promoter. Mouse Scotin and its human homologue appear to induce apoptosis in a caspase-dependent manner.

Scotin has the structure of a type I transmembrane receptor, but is located in the endoplasmic reticulum and the nuclear membrane, not in the Golgi apparatus, mitochondria, or plasma membrane. The authors are now trying to determine whether this localization pattern is required for Scotin activity, and whether the protein can promote apoptosis in response to endoplasmic reticulum stress as well as DNA damage.

The chromosomal location of the human Scotin gene, 3p21.3, is also tantalizing, as this region is rearranged or deleted in a wide range of human tumor types. Bourdon et al. found a dominant–negative phenotype in Scotin mutants, indicating that a mutation in a single allele of the gene could be sufficient to block the apoptotic activity of the protein. In preliminary studies focusing on breast cancer, researchers have already found mutations in Scotin in tumors from several patients, suggesting that Scotin may be a clinically important new tumor suppressor gene.

Alan W. Dove

alanwdove{at}earthlink.net

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF, 440K) PPT slides of all figures Alert me when this article is cited Services Email this article Similar articles in this journal Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Dove, A. W. Search for Related Content PubMed Articles by Dove, A. W. Social Bookmarking                            What's this?